A PHASE 2 STUDY TO ASSESS THE VIROLOGIC EFFICACY OF REGN10933+REGN10987 ACROSS DIFFERENT DOSE REGIMENS IN OUTPATIENTS WITH SARS-CoV-2 INFECTION
Clinical Trial Grant
Administered By
Emergency Medicine
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
December 21, 2020
End Date
April 5, 2023
Administered By
Emergency Medicine
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
December 21, 2020
End Date
April 5, 2023